Chemotherapy Flashcards
AZA, 6-MP
ANTIMETABOLITES (S phase)
- Purine analogs that dec den novo purine synthesis
- AZA metabolized to 6-MP
- Myelosuppression and metabolized by xanthin oxidase so inc toxicity if on allopurinol
Cladribine
ANTIMETABOLITE
- Purine analog - inhibits DNA polymerase and causes DNA strand breaks
- Treats hairy cell leukemia
- Myelosuppression, neurotoxic and nephrotoxic
Cytarabine
ANTIMETABOLITES
- Pyrimidine analog that inhibits DNA polymerase
- CYTopenia + anemia
5 - FU
ANTIMETABOLITE
- Pyrimidine analog act –> 5-FdUMP which attached to thymidylate synthase –> no dTMP –> dec DNA synthesis
- Myelosupression and hand-foot syndrome
Methotrexate
ANTIMETABOLITE
- Folic acid analog that competitively inhibits dihydrofolate reductase –> dec dTMP –> dec DNA synthesis
- PULM FIBROSIS, myelosupression, hepatotoxic, mouth ulcers
Which work on M phase?
- microtubule inhibitors (block mitosis)
- Paclitaxel - microtubules hyperstabilized so no breakdown/ no anaphase (stay on axel)
- Vincristine/vinblastine - bind beta-tubulin so no polymerization –> microtubules (no vines)
Topoisomerase Inhibitors
Topo I inhibitors - Irinotecan/ topotecan –> DNA cannot unwind and replicate (S phase)
Topo II inhibitors - (“two sides”) Etoposide/teniposide–> DNA degraded (G2 phase)
Cell Cycle Independent
Platinum - cisplatin, carboplatin (cross-link DNA); ototoxic
Alkylating agents also crosslink DNA - busulfan (used in CML, causes pulm fibrosis), cyclophosphamide, ifosfamide, nitrosurea (brain tumors but also CNS side effects)
Anti-tumor Abx
Bleomycin (G2 phase) - free radical break DNA strandsl causes pulm fibrosis and skin pigmentation
Doxorubicin/daunorubicin - intercalate DNA BUT cardiotoxic (give dexrazoxane)
Hydroxyurea
ANTIMETABOLITE (S phase)
- inhibits ribonucleotide reductase –> dec DNA synthesis
- CML, PV, sickle cell, melanoma
- SEVERE MYELOSUPPRESSION
Bevacizumab
MAB against VEGF
-Hemorrhage, clots, impaired wound healing
Erlotinib
EGFR tyrosine kinase inhibitor for non-small cell lung caner
Rash, diarrhea
Cetuximab
MAB against EGFR
Rash, diarrhea, inc LFTs
Imatinib
TK inhibitor of BCR-ABL fusion protein (CML) and c-kit (GI stromal tumors)
-Fluid retention
Rituximab
MAB against CD20 on B cells
-inc risk leukoencephalopathy